Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diffuse Interstitial Lung Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05963048
What this trial is testing

Rituxmab Versus IL-6 in Treating ILD

Who this might be right for
Interstitial Lung DiseaseScleroderma
Assiut University 60
Not applicableEnded earlyNCT02961335
What this trial is testing

Validation of Alveolar Probe-based Confocal Laser Endomicroscopy Descriptors in Diffuse Parenchymal Lung Diseases

Who this might be right for
Diffuse Parenchymal Lung Diseases
University Hospital, Rouen 38
Not applicableStudy completedNCT04725786
What this trial is testing

Clinical Relevance of Thoracic Echography for the Early Diagnosis of Interstitial Lung Disease in Systemic Scleroderma - Pilot Study

Who this might be right for
Systemic Sclerosis
University Hospital, Tours 30
Not applicableNot Yet RecruitingNCT07305220
What this trial is testing

Safety Profile of Ultrasound-guided Transparietal Lung Biopsy in Patients With Diffuse Interstitial Lung Disease

Who this might be right for
Interstitial Lung Disease (ILD)
University Hospital, Tours 15
Large-scale testing (Phase 3)Study completedNCT00070590
What this trial is testing

Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma

Who this might be right for
Pulmonary FibrosisScleroderma, Systemic
Actelion 132
Early research (Phase 1)Study completedNCT02426229
What this trial is testing

Safety & Suitability of Dabigatran to Inhibit Thrombin in Scleroderma

Who this might be right for
SclerodermaInterstitial Lung Disease
Medical University of South Carolina 15
Large-scale testing (Phase 3)Looking for participantsNCT06716606
What this trial is testing

Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)

Who this might be right for
Connective Tissue Diseases
GlaxoSmithKline 514
Testing effectiveness (Phase 2)Ended earlyNCT04837131
What this trial is testing

Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients

Who this might be right for
Systemic SclerosisSclerodermaDiffuse Systemic Sclerosis+16 more
Michael M. Pham 4
Post-approval studies (Phase 4)Not Yet RecruitingNCT06654934
What this trial is testing

Prednisolone for 12 Versus 6 Months to Treat Pulmonary Sarcoidosis

Who this might be right for
Sarcoidosis
Post Graduate Institute of Medical Education and Research, Chandigarh 100
Not applicableUnknownNCT03704233
What this trial is testing

The Diagnostic Yield and Safety of Transbronchial Cryobiopsy in Diffuse Parenchymal Lung Diseases

Who this might be right for
Diffuse Parenchymal Lung Diseases
Guangzhou Institute of Respiratory Disease 350
Large-scale testing (Phase 3)UnknownNCT05596786
What this trial is testing

Evaluation of Efficacy and Safety of Rituximab in Patients With Progressive Interstitial Lung Disease (ILD) With Inflammatory Component: a Multicentre Double-blind Placebo-controlled Randomized Trial

Who this might be right for
Lung Diseases
University Hospital, Tours 126
Not applicableEnrolling By InvitationNCT07061873
What this trial is testing

Physical Exercise Program for Adults With Diffuse Interstitial Lung Disease in a Pulmonary Rehabilitation Context

Who this might be right for
Interstitial Lung Disease Due to Systemic Disease (Disorder)Interstitial Lung Disease in Patients With Rheumatoid ArthritisPulmonary Fibrosis
Universidad de La Frontera 29
Not applicableUnknownNCT06171425
What this trial is testing

Evaluation of Patients With Diffuse Parenchymal Lung Diseases Regarding Frailty

Who this might be right for
Diffuse Parenchymal Lung DiseaseFrailtyPhysical Inactivity
Hacettepe University 28
Testing effectiveness (Phase 2)Study completedNCT01273766
What this trial is testing

Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies

Who this might be right for
Acute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+133 more
Wake Forest University Health Sciences 16
Not applicableStudy completedNCT00377338
What this trial is testing

Safety and Accuracy of Alveoscopy in Interstitial Lung Diseases

Who this might be right for
Respiratory Tract Diseases
University Hospital, Rouen 270
Post-approval studies (Phase 4)Study completedNCT03265405
What this trial is testing

Efficacy and Safety of Two Glucocorticoid Regimens in the Treatment of Sarcoidosis

Who this might be right for
Sarcoidosis
Post Graduate Institute of Medical Education and Research, Chandigarh 86
Testing effectiveness (Phase 2)Active Not RecruitingNCT05270668
What this trial is testing

Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007)

Who this might be right for
Diffuse Cutaneous Systemic SclerosisInterstitial Lung Disease
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 154
Large-scale testing (Phase 3)Study completedNCT01553981
What this trial is testing

A Trial of Tadalafil in Interstitial Lung Disease of Scleroderma

Who this might be right for
Lung Diseases, Interstitial
Sanjay Gandhi Postgraduate Institute of Medical Sciences 40
Not applicableLooking for participantsNCT07283081
What this trial is testing

Impact of Capillaroscopy in the Investigation of Diffuse Interstitial Pneumonias

Who this might be right for
Interstitial Lung DiseaseConnective Tissue Diseases
University Hospital, Bordeaux 48
Not applicableStudy completedNCT01762449
What this trial is testing

Morbidity and Mortality Follow Up for the Scleroderma Lung Study

Who this might be right for
Scleroderma
Duke University 158
Next Page